230 related articles for article (PubMed ID: 27664388)
1. Treatment delays, race, and outcomes in head and neck cancer.
Naghavi AO; Echevarria MI; Strom TJ; Abuodeh YA; Ahmed KA; Venkat PS; Trotti A; Harrison LB; Green BL; Yamoah K; Caudell JJ
Cancer Epidemiol; 2016 Dec; 45():18-25. PubMed ID: 27664388
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in patients with head and neck squamous cell carcinoma.
Gourin CG; Podolsky RH
Laryngoscope; 2006 Jul; 116(7):1093-106. PubMed ID: 16826042
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
[TBL] [Abstract][Full Text] [Related]
4. Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.
Dilling TJ; Bae K; Paulus R; Watkins-Bruner D; Garden AS; Forastiere A; Kian Ang K; Movsas B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e101-9. PubMed ID: 21549515
[TBL] [Abstract][Full Text] [Related]
5. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
Naghavi AO; Echevarria MI; Grass GD; Strom TJ; Abuodeh YA; Ahmed KA; Kim Y; Trotti AM; Harrison LB; Yamoah K; Caudell JJ
Cancer; 2016 Nov; 122(22):3529-3537. PubMed ID: 27479362
[TBL] [Abstract][Full Text] [Related]
6. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
[TBL] [Abstract][Full Text] [Related]
7. Asian and non-Asian disparities in outcomes of non-nasopharyngeal head and neck cancer.
Kim JD; Chang JT; Moghaddamjou A; Kornelsen EA; Ruan JY; Olson RA; Cheung WY
Laryngoscope; 2017 Nov; 127(11):2528-2533. PubMed ID: 28397269
[TBL] [Abstract][Full Text] [Related]
8. The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer.
Qureshi MM; Romesser PB; Jalisi S; Zaner KS; Cooley TP; Grillone G; Kachnic LA; Truong MT
Patient Educ Couns; 2014 Nov; 97(2):276-82. PubMed ID: 25190640
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
Zandberg DP; Liu S; Goloubeva O; Ord R; Strome SE; Suntharalingam M; Taylor R; Morales RE; Wolf JS; Zimrin A; Lubek JE; Schumaker LM; Cullen KJ
Head Neck; 2016 Apr; 38(4):564-72. PubMed ID: 25488341
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
Pai PC; Chuang CC; Chuang WC; Tsang NM; Tseng CK; Chen KH; Yen TC; Lin CY; Chang KP; Lei KF
Cancer Med; 2018 May; 7(5):1630-1641. PubMed ID: 29608254
[TBL] [Abstract][Full Text] [Related]
13. Racial survival disparities in head and neck cancer clinical trials.
Liu JC; Egleston BL; Blackman E; Ragin C
J Natl Cancer Inst; 2023 Mar; 115(3):288-294. PubMed ID: 36477855
[TBL] [Abstract][Full Text] [Related]
14. Determinants of head and neck cancer survival by race.
Ragin CC; Langevin SM; Marzouk M; Grandis J; Taioli E
Head Neck; 2011 Aug; 33(8):1092-8. PubMed ID: 20967872
[TBL] [Abstract][Full Text] [Related]
15. Management of Head and Neck Cancers With or Without Comorbid HIV Infection in Botswana.
McGinnis GJ; Ning MS; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Lin A; Zetola NM; Grover S
Laryngoscope; 2021 May; 131(5):E1558-E1566. PubMed ID: 33098322
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers.
Liu JT; Kann BH; De B; Buckstein M; Bakst RL; Genden EM; Posner MR; Som PM; Gupta V
Oral Oncol; 2016 Jan; 52():52-7. PubMed ID: 26728104
[TBL] [Abstract][Full Text] [Related]
17. Head and Neck Cancer Survival Disparities by Race and Rural-Urban Context.
Clarke JA; Despotis AM; Ramirez RJ; Zevallos JP; Mazul AL
Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1955-1961. PubMed ID: 32727721
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
19. Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.
Varlotto JM; Voland R; McKie K; Flickinger JC; DeCamp MM; Maddox D; Rava P; Fitzgerald TJ; Graeber G; Rassaei N; Oliveira P; Ali S; Belani C; Glanzman J; Wakelee HA; Patel M; Baima J; Zhang J; Walsh W
Cancer Med; 2018 Apr; 7(4):1211-1220. PubMed ID: 29533006
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
